TWENTY-FIRST CENTURY GROUP, INC.

Lobbying for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $24,000.00 income · posted Jan 19, 2026

Lobbying activity 3

Health Issues

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Medical/Disease Research/Clinical Labs

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Veterans

Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.